Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia Cells.

Bolger, GT; Licollari, A; Bagshaw, R; Tan, AM; Greil, R; Vcelar, B; Majeed, M; Sordillo, P. Anticancer Res. 2019 Mar;39(3):1161-1168. doi: 10.21873/anticanres.13225.

BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation.

Asslaber, D; Wacht, N; Leisch, M; Qi, Y; Maeding, N; Hufnagl, C; Jansko, B; Zaborsky, N; Villunger, A; Hartmann, TN; Greil, R; Egle, A. Clin Cancer Res. 2019 Mar 15;25(6):1901-1912. doi: 10.1158/1078-0432.CCR-18-1548. Epub 2018 Nov 28.

Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.

Bolger, GT; Licollari, A; Tan, A; Greil, R; Vcelar, B; Greil-Ressler, S; Weiss, L; Schön-lieb, C; Magnes, T; Radl, B; Majeed, M; Sordillo, PP. Cancer Chemother Pharmacol. 2019 Feb;83(2):265-275. doi: 10.1007/s00280-018-3730-5. Epub 2018 Nov 14.

Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5.

Bago-Horvath, Z; Rudas, M; Singer, CF; Greil, R; Balic, M; Lax, SF; Kwasny, W; Hulla, W; Gnant, M; Filipits, M. Clin Cancer Res. 2020 Nov 1;26(21):5682-5688. doi: 10.1158/1078-0432.CCR-20-0673. Epub 2020 Jun 16.

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.

Wulf, GG; Altmann, B; Ziepert, M; DxxxAmore, F; Held, G; Greil, R; Tournilhac, O; Relander, T; Viardot, A; Wilhelm, M; Wilhelm, C; Pezzutto, A; Zijlstra, JM; Van Den Neste, E; Lugtenburg, PJ; Doorduijn, JK; van Gelder, M; van Imhoff, GW; Zettl, F; Braulke, F; Nickelsen, M; Glass, B; Rosenwald, A; Gaulard, P; Loeffler, M; Pfreundschuh, M; Schmitz, N; Trumper, L. Leukemia. 2021 Jan;35(1):143-155. doi: 10.1038/s41375-020-0838-5. Epub 2020 May 7.

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.

Burtness, B; Harrington, KJ; Greil, R; Soulieres, D; Tahara, M; de Castro, G; Psyrri, A; Baste, N; Neupane, P; Bratland, A; Fuereder, T; Hughes, BGM; Mesia, R; Ngam-phaiboon, N; Rordorf, T; Ishak, WZW; Hong, RL; Mendoza, RG; Roy, A; Zhang, YY; Gumuscu, B; Cheng, JD; Jin, F; Rischin, D. Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1.

Prediction of Distant Recurrence Using EndoPredict Among Women with ER +, HER2 – Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only.

Filipits, M; Dubsky, P; Rudas, M; Greil, R; Balic, M; Bago-Horvath, Z; Singer, CF; Hlauschek, D; Brown, K; Bernhisel, R; Kronenwett, R; Lancaster, JM; Fitzal, F; Gnant, M. Clin Cancer Res. 2019 Jul 1;25(13):3865-3872. doi: 10.1158/1078-0432.CCR-19-0376. Epub 2019 May 7.

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a rando-mised, double-blind, placebo-controlled, phase 3 trial.

Gnant, M; Pfeiler, G; Steger, GG; Egle, D; Greil, R; Fitzal, F; Wette, V; Balic, M; Hasl-bauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Jakesz, R; Marth, C; Sevelda, P; Mlineritsch, B; Exner, R; Fesl, C; Frantal, S; Singer, CF. Lancet Oncol. 2019 Mar;20(3):339-351. doi: 10.1016/S1470-2045(18)30862-3. Epub 2019 Feb 19.

Association between antibiotics use and outcome in patients with NSCLC trea-ted with immunotherapeutics.

Huemer, F; Rinnerthaler, G; Lang, D; Hackl, H; Lamprecht, B; Greil, R. Ann Oncol. 2019 Apr 1;30(4):652-653. doi: 10.1093/annonc/mdz021.

Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study.

Lang, D; Huemer, F; Rinnerthaler, G; Horner, A; Wass, R; Brehm, E; Akbari, K; Gra-nitz, M; Hutarew, G; Kaiser, B; Greil, R; Lamprecht, B. Target Oncol. 2019 Dec;14(6):707-717. doi: 10.1007/s11523-019-00679-9.